Kasan Insight :: Korea IP Law Blog

Korea IP Law and Practice on Patent, Design, Trademark, Copyright, Trade Secrets and Unfair Competition

Showing posts with label biosimilar. Show all posts
Showing posts with label biosimilar. Show all posts

IPT Decided One of 2 Patents on Herceptin (trastuzumab) Listed in Green List of KFDA as being Invalid

›
Roche launched Herceptin for the treatment of HER2-positive metastatic breast cancer in Korea. And Celltrion, a Korean Pharmaceutical compa...

Remicade v. Remsima - Trademark Dispute between J&J and Celltrion

›
Remicade is a monoclonal antibody to treat RA. This blockbuster biopharmaceutical product was developed and has been sold by Centocor that ...

Roche v. Celltrion re: Herceptin Patent Infringement Lawsuit over Biosimilar Herzuma

›
Celltrion, a Korean company developed a biosimilar Herzuma to Herceptin (trastuzumab) and obtained market approval (MA) for a biosimilar He...
›
Home
View web version
Powered by Blogger.